Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 35,000 LXEO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 35,000 | n/a |
| Oct 30, 2025 | 89bio, Inc. (ETNB) | Disposition to Issuer | 40,000 | n/a |
| Jun 30, 2025 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 25,000 | n/a |
| Jun 26, 2025 | WW INTERNATIONAL, INC. (WW) | Exercise/Conversion | 40,486 | n/a |
| Feb 5, 2025 | 89bio, Inc. (ETNB) | Grant/Award | 56,400 | n/a |
| Jan 2, 2025 | WW INTERNATIONAL, INC. (WW) | Grant/Award | 3,696 | n/a |
| Oct 2, 2024 | WW INTERNATIONAL, INC. (WW) | Grant/Award | 3,696 | n/a |
| Jul 3, 2024 | WW INTERNATIONAL, INC. (WW) | Grant/Award | 3,696 | n/a |
| Jun 27, 2024 | Lexeo Therapeutics, Inc. (LXEO) | Grant/Award | 18,000 | n/a |
| Apr 3, 2024 | WW INTERNATIONAL, INC. (WW) | Grant/Award | 3,696 | n/a |